Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for Emedastine intermediate ensures >99% purity. Cost-effective manufacturing solution for reliable pharmaceutical intermediate supply chain partners.
Patent CN119775259B details a novel resin-supported catalyst method for high-purity Amatinib intermediate production, offering significant supply chain and cost advantages.
Novel patent CN115466214B offers safer route for Valicarb intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN119546579A enables high-yield synthesis of prostate cancer drug intermediates, ensuring supply chain stability and significant cost efficiency.
Discover advanced manufacturing of chiral 1,4-dihydro-4-(3-nitrophenyl)-3,5-pyridinedicarboxylates. A robust resolution process for calcium antagonist intermediates ensuring high purity and supply stability.
Patent CN1269795A reveals a scalable route for chiral alkoxyfuranone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel preparation method for Ozanimod intermediate offering high purity and scalable manufacturing solutions for pharmaceutical supply chains.
Novel patent CN117886725A details a Pd-free synthesis route for apremilast intermediates, offering cost reduction in API intermediate manufacturing and enhanced supply chain reliability for global buyers.
Novel enzymatic route for Sacubitril intermediate. High purity, cost-effective, scalable manufacturing for cardiovascular API supply chains.
Patent CN113816913B reveals improved oxazepam intermediate synthesis with reduced waste and enhanced safety for reliable pharmaceutical intermediates supply chains.
Novel patent CN117447387A enables cost-effective chiral intermediate production. Enhances supply chain reliability and purity for global API manufacturing partners.
Novel patent CN104557975A offers efficient everolimus intermediate synthesis. Reduces impurities, ensures supply chain stability for pharmaceutical manufacturing.
Novel nitrite substitution method enhances safety and reduces cost for silodosin intermediate manufacturing supply chain reliability and purity.
Patent CN103497202B reveals safer reduction method for dorzolamide intermediate. Enhances supply chain reliability and reduces environmental toxicity significantly.
Patent CN104402873A reveals efficient olmesartan intermediate synthesis. High purity, low cost process ensures supply chain stability for pharmaceutical intermediates manufacturing.
Novel Kulinkovich route for Saxagliptin intermediate offers mild conditions and high yield. Reliable supply chain partner for DPP4 inhibitor manufacturing.
Patent CN108059599B reveals a cost-effective route for Venetoclax intermediates. Discover how this novel one-pot method reduces production costs and ensures high purity.
Patent CN113512733B details an electrochemical NHK reaction for Eribulin intermediate ERB, offering greener synthesis, reduced reaction time, and improved scalability for pharmaceutical manufacturing.
Patent CN104045513A reveals cost-effective Empagliflozin intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Novel microchannel nitration process for irinotecan intermediate ensures safety and yield. Supply chain reliability improved via intrinsic safety design and reduced waste discharge for global buyers.